Find care settings where the device fits its authorized use and a real workflow, then qualify clinical, operational, technical, procurement, implementation, safety, and economic requirements.
In brief
Start with the device's authorized use, approved claims, and the care settings where it fits an existing clinical workflow. Map the clinical champion and institutional approvers, then confirm patient or procedure volume, evidence needs, procurement, facilities, integration, training, support, and total cost before forecasting adoption.
Document classification, marketing status, intended use, indications, contraindications, warnings, intended users and settings, approved claims, evidence, and geography before choosing a segment. Commercial messaging must follow the current regulatory position, not the team's desired use case.
Specify device, accessories, consumables, software, integration, installation, facilities, training, credentialing, service, maintenance, updates, safety controls, financing, and replacement life. Buyers evaluate the system and workflow, not only the unit price.
A clinician may validate utility while administration, value analysis, procurement, IT, security, biomed, infection prevention, finance, legal, and executives control other gates. Identify who can approve each requirement and who owns implementation.
A specialty, location, or advertised service can suggest care-setting fit. It cannot establish patient volume, clinical need, current equipment, evidence acceptance, reimbursement, budget, or purchase intent. Confirm these conditions without requesting patient-identifiable information.
| Model | Best for | Tradeoff |
|---|---|---|
| Clinical education and evidence-led inbound | Devices whose adoption requires clinicians and administrators to understand indications, evidence, patient selection, workflow, safety, implementation, and economic tradeoffs. | Education can attract researchers, students, patients, and unsupported-use questions. Separate scientific, medical, training, and promotional content with appropriate review, authorship, claims, and follow-up routes. |
| Named-account selling | A field or inside team with a precise setting, specialty, approved message, buying-committee map, demonstration process, technical support, and account-based follow-up. | Care-setting data identifies plausible sites but not clinical need or purchase authority. Research only verified facts and route discovery without implying knowledge of patients or internal performance. |
| Distributors, GPOs, and health-system contracts | Products where channel reach, contracted access, logistics, local support, purchasing leverage, or system standardization matter more than direct account ownership. | Access does not guarantee clinician adoption or utilization. Clarify territory, pricing, inventory, training, support, account ownership, data, compliance, and conflict rules. |
| Conferences, demonstrations, and peer programs | Products buyers need to see, handle, compare, or discuss with qualified users before evaluation. | Badge scans and demonstration attendance are not opportunities. Qualify setting, use case, authority, timeline, disclosure, transfer-of-value, and approved follow-up before routing to sales. |
| Outsourced demand generation | A company with approved content, precise account criteria, trained routing, compliant systems, sales capacity, and reporting through evaluation, purchase, implementation, and use. | Meeting targets can reward wrong specialties, junior contacts, unsupported applications, no budget, or sites that cannot implement. Manufacturer review and oversight remain essential. |
A narrower buying group may accelerate evaluation when the device maps to frequent procedures and an owner-clinician has authority. Confirm financing, facilities, staffing, service, and implementation rather than assuming owner control.
Groups can support standardization and rollout, but clinical governance, capital approval, IT, procurement, training, service coverage, and local adoption may be centralized or divided.
Complex devices may require clinical sponsorship, value analysis, supply chain, biomed, IT and security, infection prevention, facilities, finance, legal, and executive review. A department contact alone does not establish an approved project.
These settings can fit monitoring, screening, dispensing, administration, or home-use support only where the product's authorized use, staffing, workflow, quality controls, and purchasing route align.
The table shows how many US dental practices are available for the imaging-system example. Public business data cannot establish procedure volume, installed equipment, replacement plans, clinical preference, technical fit, budget, or buying authority. Those questions belong in practice-level discovery.
| Category | Businesses | Unique emails / business coverage | Unique phones / business coverage |
|---|---|---|---|
| Dentist | 230,000 | 60,500 (33.7%) | 176,000 (97.6%) |
| Dental Clinic | 16,500 | 8,400 (38.7%) | 22,000 (86%) |
Evaluates indications, patient selection, evidence, clinical workflow, safety, professional acceptance, and whether the device addresses a meaningful care decision.
Owns staffing, scheduling, rooms, throughput, training, implementation, service disruption, utilization, and coordination across stakeholders.
Evaluate vendor route, contracts, evidence, alternatives, capital or operating budget, total cost, reimbursement assumptions, service terms, and approval governance.
Control device inventory, connectivity, interoperability, access, maintenance, cybersecurity, data flow, electrical and spatial requirements, and technical acceptance.
A verified new service, site, procedure, or access goal can create a project when clinical leadership and administration have defined scope, evidence, infrastructure, and funding.
End of support, reliability, maintenance, standardization, image or output quality, integration, or lifecycle planning can prompt evaluation. Do not claim a competitor's system is obsolete without evidence.
Clinical teams may seek a different workflow, safety control, turnaround time, data path, or staffing model. Validate the baseline and success criteria rather than diagnosing a problem from outside.
An RFI, RFP, capital request, formulary review, or contract window provides a real route. Follow procurement and conflict rules instead of trying to bypass institutional governance.
[Practice] provides [verified dental service] in [location]. Our imaging system is intended for [approved use stated within labeling] in [supported setting]. Who evaluates imaging workflow and equipment purchases, and is the current system scheduled for review?
Require authorized use, setting and workflow fit, clinical owner, evidence path, patient or procedure relevance, buying committee, procurement route, implementation capacity, timing, budget, and supportable economics.
Track routed conversation, clinical discovery, stakeholder map, evidence review, demonstration, technical and security review, value analysis, sourcing, contract, order, installation, training, acceptance, and loss reason.
Measure installation readiness, training completion, time to first appropriate use, utilization within intended use, support cases, downtime, consumables, safety feedback, and agreed operational outcomes.
Include acquisition, demonstrations, clinical support, channel margin, installation, integration, training, warranty, field service, software, security updates, consumables, financing, collection, and account expansion.
A recognizable logo is not a target if indication, user, setting, geography, service, distribution, or training requirements do not fit.
Interest from one contact cannot carry adoption when no clinician owns the use case or required procurement, technology, facilities, and finance gates are unavailable.
Low relevant use, unsuitable patients, missing staff, incompatible systems, inadequate facilities, training limits, or unsupported service coverage can make adoption impractical.
Do not qualify a sale on speculative reimbursement, utilization, labor savings, consumable pull-through, financing, or outcomes. Identify assumptions, owner, evidence, and sensitivity.
FDA explains that classification depends on intended use and indications and determines applicable regulatory controls and premarket route. FDA also states that establishment registration and device listing do not denote approval, clearance, or authorization. Legal, regulatory, medical, and quality teams should govern current claims and audiences.[1][2]
FDA's labeling guidance addresses intended use and explains that sellers intending a device for another use may incur labeling obligations. Keep emails, pages, decks, demonstrations, testimonials, comparisons, and representative statements accurate, balanced, substantiated, and within approved review processes.[3]
FDA describes premarket cybersecurity requirements for cyber devices, including vulnerability management, updates and patches, and a software bill of materials. Buyers may require additional technical and security review; do not reduce this to a generic feature claim.[4]
CMS identifies applicable manufacturers and GPOs as Open Payments reporting entities and covered recipients under the program. HHS OIG warns about problematic vendor relationships and notes institutional restrictions. Review consulting, training, travel, meals, demonstrations, grants, discounts, and referral arrangements under applicable rules and policies.[5][6]
Research and data review by
Raphael CanyasseSphereScout founder; review covers source use, list-building, and data methodology
Updated August 10, 2026
U.S. Food and Drug Administration - Accessed August 10, 2026
U.S. Food and Drug Administration - Accessed August 10, 2026
U.S. Food and Drug Administration - Accessed August 10, 2026
U.S. Food and Drug Administration - Accessed August 10, 2026
Centers for Medicare & Medicaid Services - Accessed August 10, 2026
HHS Office of Inspector General - Accessed August 10, 2026
Clinical education builds understanding, named-account selling reaches precise care settings, distributors and contracts create access, and demonstrations support evaluation. The right mix depends on device risk, evidence, buying committee, sales capacity, channel strategy, and implementation model. Measure adoption, not meetings.
Start with the role that owns the clinical use case, then map administration, operations, value analysis, procurement, finance, biomed, IT, security, privacy, facilities, infection prevention, legal, and executives as the product requires. One contact rarely owns the entire decision.
The account fits the device's authorized use and care setting, has a relevant workflow and clinical owner, and can complete evidence, procurement, and technical review. It also needs realistic implementation, service, budget, timing, utilization, and total-cost assumptions.
No. It can identify plausible care settings, specialties, locations, and contact routes. It cannot reveal patient need, procedure volume, installed equipment, clinical preference, budget, procurement status, or purchase intent. Verify those conditions directly without requesting patient-identifiable information.
After account criteria, regulatory status, approved claims, content review, stakeholder routing, demonstration rules, data handling, sales handoff, implementation capacity, vendor oversight, and evaluation-to-adoption reporting are stable.
Compare adjacent industries that use some of the same business categories but require different qualification rules.
Choose whether the pipeline is for patients, professional referrals, or healthcare accounts, then target the right setting and stakeholder.
Define the client problem your firm can solve, choose channels that transfer expertise and trust, and qualify whether a conversation can become a viable engagement.
Choose a client-acquisition mix, define an agency niche, and build a qualified prospect list around one service offer.
Choose an acquisition mix, define the environments your MSP can support, and build qualified account lists around one managed-service offer.
Find sites with a real security project, then qualify the requirement, current system, decision team, response process, and service area.
Choose a care setting and geography, then verify clinical fit, stakeholders, evidence, procurement, technology, facilities, training, service, safety, timing, and economics.